What We Do
A world-leading native mass spectrometry platform
Oxford Mass Technologies (OMass) specializes in applying state-of-the-art mass spectrometry platforms to the characterisation of intact protein assemblies, often referred to as native mass spectrometry. By preserving the structures of protein assemblies, we are able to provide structural insights into large, dynamic complexes.
Our recent technological breakthroughs and IP portfolio surrounding the use of native mass spectrometry for membrane proteins provides new exciting applications towards high-value receptors and drug targets which are challenging for other biophysical techniques.
We are committed to providing our technology and know-how to biotechnology and pharmaceutical companies to assist in tackling challenging drug targets and biotherapeutics, within a dynamic and collaborative framework.